Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Current Assets: 2020-2024

Historic Current Assets for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $20.7 million.

  • Biofrontera's Current Assets fell 14.87% to $14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.4 million, marking a year-over-year decrease of 14.87%. This contributed to the annual value of $20.7 million for FY2024, which is 10.29% down from last year.
  • Biofrontera's Current Assets amounted to $20.7 million in FY2024, which was down 10.29% from $23.1 million recorded in FY2023.
  • Biofrontera's 5-year Current Assets high stood at $46.4 million for FY2021, and its period low was $19.6 million during FY2020.
  • For the 3-year period, Biofrontera's Current Assets averaged around $29.0 million, with its median value being $23.1 million (2023).
  • As far as peak fluctuations go, Biofrontera's Current Assets spiked by 137.13% in 2021, and later crashed by 46.51% in 2023.
  • Over the past 5 years, Biofrontera's Current Assets (Yearly) stood at $19.6 million in 2020, then skyrocketed by 137.13% to $46.4 million in 2021, then dropped by 7.07% to $43.1 million in 2022, then crashed by 46.51% to $23.1 million in 2023, then decreased by 10.29% to $20.7 million in 2024.